Originally published on Illumina News Center Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact ...

It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and ...

Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...

Illumina, Inc., a leader in DNA sequencing and array technologies, has launched a pilot proteomics program analyzing 50,000 ...

Macrogen has pioneered genome sequencing and testing in Korea, becoming a reference company and supporting the development of technology in the country. However, it would be wrong to limit Macrogen's ...

In developed markets, especially those of Japan, USA and EU, medical organizations and practitioners are reputed for being conservative, and changing suppliers or adopting new technologies for medical ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a ...

Illumina, Inc. ILMN has announced a series of updates to its NovaSeq X Series. The company’s single-flow-cell NovaSeq X Sequencing System is now available for the first time, alongside the ...

Illumina, Inc. ILMN has announced a series of updates to its NovaSeq X Series. The company’s single-flow-cell NovaSeq X Sequencing System is now available for the first time, alongside the software v1 ...

Illumina, Inc. , a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside ...